The AD group exhibited higher levels of tau (377.51 ± 155.16 pg/mL) and phosphorylated tau (p-tau) (37.23 ± 16.11 pg/mL) compared to the MCI group and the CN group (p < 0.001). This evidence concerns the gene MAPT and Alzheimer disease.